2Karen L. Furie,LarryB. Goldstein,Gregory W. Albers,Pooja Khatri,Ron Neyens,Mintu P. Turakhia,Tanya N. Turan,Kathryn A. Wood,严晓铭(译),何晟(译),丁妹(译),柯开富(译).口服抗栓药预防非瓣膜性心房颤动患者卒中：美国心脏协会／美国卒中协会对医疗卫生专业人员的科学建议[J].国际脑血管病杂志,2012,20(12):881-892. 被引量：3
5Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials. Arch Intern Med, 1994, 154: 1449-1457.
6Stroke Risk in Atrial Fibrillation Working Group. Independent predictors of stroke in patients with atrial fibrillation: a systematic review. Neurology, 2007, 69: 546-554.
7Loewen P, Dahri K. Risk of bleeding with oral anticoagulants: an updated systematic review and performance analysis of clinical prediction rules. Ann Hematok 2011, 90: 1191-1200.
8Goldstein LB, Bushnell CD, Adams RJ, et al; American Heart Association Stroke Council; Council on Cardiovascular Nursing; Council on Epidemiology and Prevention; Council for High Blood Pressure Research,; Council on Peripheral Vascular Disease, and Interdisciplinary Council on Quality of Care and Outcomes Research. Guidelines for the primary prevention of stroke: a ghdeline for healthcare professionals from the Armx'ican H"t Association/American Stroke Association. Stroke, 2011, 42: 517- 584.
9Furie KL, Kasner SE, Adams RJ, et al; Arr'ican Heart Association Stroke Council, Council on Cardiovascular Nursing Council on Clinical Cardiology, and Interdisciplinary Council on Quality of Cea'e and Outcomes Research. Guidelines for the prevention of stroke in patients with stroke or transient ischerrhc attack: a guideline for healthcare professionals fi'om the Arm'rican Hart Association/American Stroke Association. Stroke, 2011, 42: 227-276.
10Gage BF, van Walraven C, Pearce L, et al. Selecting patients with atrial fibrillation for anticoagulation: stroke risk stratification in patients taking aspirin. Circulation, 2004, 110: 2287-2292.
